Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Ampio Pharmaceuticals Inc. (NYSEMKT: AMPE) shares surged 15.30 percent to close at $6.18 a share Wednesday. The stock traded between $5.95 and $7.00 on volume of 2.26 million shares traded. The company announced results from a clinical trial of Ampion for the treatment of Osteoarthritis of the knee that showed a “clinically meaningful reduction in pain.” Shares of Ampio Pharmaceuticals have gained approximately 72.0 percent year-to-date.
Get more information on Ampio Pharmaceuticals and free access to the in-depth equity report at:
BioScrip Inc. (NASDAQ: BIOS) shares dropped 3.81 percent to close at $13.63 a share Wednesday. The stock traded between $13.15 and $13.64 on volume of 4.17 million shares traded. The company announced an upsized offering of roughly 6.9 million shares by shareholders. Shares of BioScrip have gained approximately 26.0 percent year-to-date.
Get more information on BioScrip and free access to the in-depth equity report at:
Millennial Media, Inc. (NYSE: MM) shares dropped 18.82 percent to close at $6.90 a share Wednesday. The stock traded between $6.36 and $7.34 on volume 15.92 million shares traded. The company reported GAAP net loss grew to $3.1 million for the second quarter of 2013, from a GAAP net loss of $2.2 million a year ago. Shares of Millennial Media have gained approximately 45.0 percent year-to-date.
Get more information on Millennial Media and free access to the in-depth equity report at:
ExOne Co. (NASDAQ: XONE) shares declined 11.14 percent to close at $67.24 a share Wednesday. The stock traded between $63.52 and $70.85 on volume of 1.57 million shares traded. The company stated that revenues for the 2013 are expected to be at the lower end of its previous guidance of $48 million to $52 million.
Get more information on ExOne and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...